John Wiley and Sons Ltd, Jan 2011, Pages: 419
HumanStemCellTechnology and Biology: A Research Guide and Laboratory Manual HumanStemCellTechnology & Biology: A Research Guide and Laboratory Manual integrates readily accessible text
Jain PharmaBiotech, May 2012, Pages: 1015
identification of surface markers
ALDESORTER system for isolation of stem cells
Dynabead technology for cell sorting
Molecular beacons for specific detection and isolation of stem cells
Multitarget magnetic
Axis Research Mind, July 2010, Pages: 468
THE DESERVING
GOVERNMENTAL POLICY IN DIFFERENT REGIONS
AMERICANS
UNITED STATES
EUROPE
ASIA-PACIFIC
AFRICA
EMBRYONIC STEMCELL RESEARCH “CONTROVERSY”
CREATION OF EMBRYONIC CHARACTERISTICS FROM HUMAN
Industry Experts, July 2010, Pages: 216
Cell Sciences plc
Geron Gets the Green Signal from FDA to Begin World's First Human Clinical Trial of Embryonic StemCell-Based Therapy
Advanced CellTechnology, Inc and CHA Biotech Co, Ltd in a Joint
Axis Research Mind, July 2010, Pages: 472
PATENT AND CULTIVATION OF PLURIPOTENT STEM CELLS
APPLICATION ON CHEMOKINE TECHNOLOGY TO INCREASE EFFICACY OF TISSUE-SPECIFIC STEMCELL HOMING IN COPD TREATMENT
TESTING OF RETINAL PIGMENT FROM HUMAN
Axis Research Mind, May 2011, Pages: 692
STEM CELLS CALLED PARTHENOGENETIC CELLS, WHICH ARE DEVELOPED BY UNFERTILIZED HUMAN EGGS-ETHICAL CONSIDERATIONS AND MEDICAL ADVANTAGES
ADVANCED CELLTECHNOLOGY AND THE ROSLIN INSTITUTE ANNOUNCE AGREEMENT
GBI Research, Nov 2011, Pages: 160
needs results in loss of growth opportunities for the pharmaceutical industry. Stemcell research is a technology that has the potential to serve these unmet needs by providing alternatives to
BioInformant, May 2012, Pages: 118
than the federal government on human embryonic stemcell (hESC) research. Private sources also contribute a huge about of funding, with analysis of recent large gifts summing to over $1.7 billion
Axis Research Mind, July 2010, Pages: 410
DETECTION
CHALLENGES TO CULTURE
STANDARD GUIDELINE FOR IPS TECHNOLOGY
C. ADVANCES IN STEMCELL RESEARCH
D. SIMILARITIES AND DIFFERENCES BETWEEN EMBRYONIC AND ADULT STEM CELLS
E. THE CONTROVERSY ON STEMCELL
Frost & Sullivan, July 2010, Pages: 81
Obama’s March 2009 executive order lifting the ban on federal funding for human embryonic stemcell research was quickly followed by National Institutes of Health (NIH) guidelines for humanstemcell
Global Industry Analysts, Inc., Feb 2011, Pages: 566
Cell Growth
Medium 36
ThermoGenesis to Launch Res-Q System 37
Invitrogen to Introduce New Technology for Safe StemCell
Treatment 37
Millipore Unveils MilliTrace™ StemCell Lines 38
Millipore
Markets and Markets, Nov 2009, Pages: 229
categorizes the global stemcell market as follows:
- StemCell Products (adult stemcell, human embryonic stemcell, and other stemcell types)
- StemCell Services (stemcell banking, stemcell acquisition
Industry Experts, Oct 2011, Pages: 282
CordLife’s Advanced HumanStemCell Debuts in Hong Kong
StemCyte’s First StemCell Bank Opened in India
First Cord Blood Processing and Cryopreservation Facility Opens in the Philippines
PathCare Labs Launches
BioInformant, Jan 2010, Pages: 126
Opportunities in Human Embryonic StemCell (hESC) Products Human embryonic stem cells (hESCs) are stem cells derived from the inner cell mass of a blastocyst, which is a stage reach 4-5 days post
GBI Research, Feb 2010, Pages: 77
market sizing, technology adoption framework and business models for the stemcell market.
- A cross-country analysis for regulatory framework, investments, research clusters and support including the US
Fuji-Keizai USA, Inc, Jan 2010, Pages: 141
focused cells used in cell screening campaigns used in pre-clinical drug development. The customized stemcell-derived human cells would eliminate the need to sacrifice millions of lab animals that are
Decision Resources, Inc., March 2010, Pages: 21
stem cells without having to work with human embryos. What is the current state of iPS cell research? What are the technology’s strengths and weaknesses?
- iPS celltechnology is in its early stages
Centient Consulting, Inc, Sep 2006, Pages: 83
dead end. As a matter of fact, stemcell researchers and companies are remarkably successful, considering that it often takes decades before a technology matures enough that it is ready for the market
Fuji-Keizai USA, Inc, Dec 2011, Pages: 173
cells, such as human embryonic stem cells (hESCs) or induced pluripotent stemcells (iPSCs), as well as various kinds of adult stem cells to make customized, disease focused cells used in cell screening
